Stanford University's Anesthesia Informatics and Media (AIM) lab is doing seriously innovative, cool stuff with healthcare, including offering a Patient Engagement Healthcare Design Class this fall. Today I'm sharing some of the key learnings from Week One, appropriately named, Introduction to Patient Engagement Design. Our lecture for week one was led by Kyra Bobinet, MD, … Continue reading What’s in it for me? Patient Engagement Healthcare Design
Every day, oncology clinicians are asked to do more with less. What I mean by this is, reimbursement for many services has gone down or is inadequate, and physicians are asked to do more during a patient visit with less time available. Yesterday I had the wonderful opportunity to present to a local oncology department in … Continue reading Doing More with Less: Capturing Adequate Cancer Family History
Something must be in the water. First, in January, there was the absurd cancer patient shaming that the awful Keller duo vomited on the public. Now, we have Kohl's and Susan G. Komen undermining the work of METAvivor, the only organization in the U.S. dedicated to awarding research funding for Stage IV breast cancer. METAvivor … Continue reading Drowning in Pink
Ever left your doctor's office and felt frustrated, irritated and generally annoyed? I think we all have. Today I'd like to talk a bit about patient experience, and tell a story that highlights a practice that I think is getting it right. Patient experience is not just your interaction with your healthcare provider. To me, … Continue reading Getting Patient Experience Right.
Women diagnosed with breast cancer in DC's Wards 7 & 8 have a lower chance of survival than the national average. Watch out, breast cancer. We're coming for you. It's exciting times at Breast Care for Washington. While we haven't been super active in the public eye since our official launch in November 2012, we've … Continue reading Watch out, breast cancer. We’re coming for you.
I'm hesitant to post this one. Today many of my hardworking, dedicated former colleagues at Lilly will find out they no longer have a job. I believe some of this could have been avoided. To Lilly's credit, it has made tremendous efforts to keep as many sales people as it could over the years while … Continue reading Musings of an ex-pharma rep.
One of the unique phenomenons of cancer patient care is the cancer patient support group. Not that other disease states don't have these groups, but cancer patient support groups are generally very well attended. Patients connect with other patients and life long mentor/mentee and friend relationships develop at these groups. Tonight I'm off to attend … Continue reading Patient Support Groups Matter
Last week marked a very exciting moment for anyone with any involvement in breast cancer patient care, including, and especially, for breast cancer patients. On February 22 2013, the FDA approved Kadcyla, a new treatment for HER-2 positive metastatic breast cancer. Kadcyla was formerly known to many in the cancer world as T-DM1 and has … Continue reading New hope in HER-2 Positive Metastatic Breast Cancer